About this event
If you are considering a potential investment in children's health or biotechnology, we would love for you join. Intro to AlphaRose is a live session to provide you with a deeper understanding of AlphaRose's mission, plan and the ability to ask questions and have a discussion with the CEO, Casey McPherson. AlphaRose is currently running a Reg CF investment round, allowing anyone to invest in the future of genetic medicine.
This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk
Alpha Rose is dedicated to developing innovative genetic therapies aimed at treating rare genetic diseases in children, addressing the significant gap in available treatments for the 200 million affected children worldwide.
